Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial
Avezum et al., The Lancet Regional Health - Americas, doi:10.1016/j.lana.2022.100243
https://c19hcq.org/avezum.html